SCHEMBL20197337

SCHEMBL20197337

[O-][S+](Nc1ccc(-c2csc(-c3ccccc3-c3ccccc3)n2)c(Cl)c1)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.40
CYP1A1 P04798 5/20 0.40
CYP1B1 Q16678 5/20 0.40
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 3/20 0.39
KDM4E B2RXH2 2/20 0.39
EIF4E P06730 6/20 0.39
CYP19A1 P11511 1/20 0.39
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
SMO Q99835 2/20 0.36
C1S P09871 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20197443 0.84 C1S (0.39) CYP1A2CYP1A1CYP1B1RAB9ASMN1; SMN2
SCHEMBL20197479 0.84 EIF4E (0.39) CYP1A2RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL20197238 0.82 CYP19A1 (0.44) RAB9ASMN1; SMN2NPC1KDM4EEIF4E
SCHEMBL16535542 0.79 KDM1A (0.42) CYP1A2CYP1A1CYP1B1RAB9ASMN1; SMN2
SCHEMBL20197304 0.79 CDK2 (0.39) CYP1A2CYP1A1CYP1B1RAB9ASMN1; SMN2
SCHEMBL20197481 0.79 EIF4E (0.37) RAB9ASMN1; SMN2NPC1KDM4EEIF4E
SCHEMBL20197448 0.78 PTGER1 (0.38) RAB9ASMN1; SMN2NPC1KDM4EEIF4E
SCHEMBL20197301 0.77 KDM4E (0.34) RAB9ASMN1; SMN2NPC1KDM4EEIF4E
SCHEMBL20197235 0.77 SREBF2 (0.42) KDM4EALDH1A1MAPT
SCHEMBL20197159 0.77 CYP19A1 (0.33) CYP1A2CYP1A1CYP1B1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3038622-B1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE MEDIVATION TECH LLC (US) 2018-05-30 EP disclosed